Mycoplasma Genitalium Treatment in Nepal The Emerging STI — Resistance-Aware Diagnosis + Correctly-Guided Treatment
Specialist care for Mycoplasma genitalium — the emerging STI causing persistent urethritis/cervicitis/PID, notorious for macrolide resistance. Resistance-aware treatment at Thamel Clinic.
Medically Reviewed Content
Reviewed by: STD Specialist (MBBS, MD - Medicine)
NMC Registration:
Last medical review: June 1, 2026
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
M. Genitalium in Nepal
- Under-diagnosed — routine chlamydia tests don't include it; it's a common cause of "persistent urethritis."
- Macrolide resistance high — global resistance to azithromycin is substantial; resistance-guided treatment is essential.
- NGU cause — a significant proportion of non-gonococcal urethritis.
- PID contribution — contributes to female PID/cervicitis alongside chlamydia/gonorrhea.
Mycoplasma Genitalium — the Emerging, Resistant STI
Mycoplasma genitalium is an **emerging sexually-transmitted pathogen** — a cause of urethritis in men and cervicitis/PID in women. It's clinically similar to chlamydia (urethral discharge, dysuria, pelvic pain) but is often missed because routine chlamydia tests don't detect it.
The critical feature is its **notorious antimicrobial resistance** — high rates of macrolide (azithromycin) resistance mean the standard single-dose chlamydia regimen frequently fails. Correct treatment requires **resistance-guided selection**, which is why blind re-treatment often fails.
This page explains the condition, the testing, and the resistance-aware approach that distinguishes correct M. genitalium management.
The Presentation
Urethritis (men)
Persistent or recurrent urethral discharge + dysuria — often after "chlamydia" treatment failed.
Cervicitis (women)
Mucopurulent cervical discharge, contact bleeding, dyspareunia — often overlooked.
PID
Contributes to pelvic inflammatory disease — pelvic pain, the infertility/ectopic risk.
Persistent/recurrent
The classic clue — symptoms that recur after standard therapy.
The Testing
**NAAT is the only reliable detection** — the organism can't be cultured easily. A dedicated M. genitalium NAAT (not the routine chlamydia test) is required — typically on first-void urine or a urethral/vaginal swab.
**Resistance testing** — where available, the macrolide-resistance mutation detection guides the antibiotic selection. We test specifically for it.
The Resistance-Aware Treatment
Resistance-guided
Where resistance testing is available — the macrolide-susceptible get doxycycline + azithromycin; the resistant get moxifloxacin or pristinamycin.
The staged approach
Doxycycline first (reduces the organism load) followed by the guided second agent — the recommended resistance-aware approach.
Don't re-dose azithromycin blindly
Single-dose azithromycin frequently fails — the resistance means blind re-treatment is often futile.
Test-of-cure
A repeat NAAT after treatment confirms clearance — important given the resistance.
Partner + PID Implications
The partner must be treated — the resistant organism transmits. PID implications (infertility, ectopic) mean the female cases are managed as seriously as chlamydial PID.
Given the resistance, the test-of-cure and the partner-treated-together are both essential to prevent ping-pong reinfection.
M. Genitalium Care & Costs
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| Specialist consultation | Assessment + differential | Rs. 450 |
| M. genitalium NAAT | The specific detection | Lab rate |
| Resistance-guided treatment | Correct antibiotic | Per case |
| Test-of-cure + partner | Confirms clearance + prevents reinfection | Coordinated |
Transparent pricing; confirm current rates on booking.
Why Thamel Clinic for M. Genitalium
- Specific testing — the dedicated NAAT, not just the routine chlamydia.
- Resistance-aware — the guided antibiotic, not blind re-treatment.
- Persistent cases — we find it in the "treatment-failed" cases.
- Test-of-cure — confirms the actual clearance.
- Confidential — private, non-judgmental.
Frequently Asked Questions
What is Mycoplasma genitalium?
An emerging STI causing urethritis/cervicitis/PID — similar to chlamydia but missed by routine chlamydia tests and notorious for antibiotic resistance.
Why did my chlamydia treatment not work?
Often it's actually M. genitalium — which isn't detected by the routine test and has high azithromycin resistance. The specific NAAT identifies it.
Is it treatable?
Yes — with the resistance-aware approach (staged doxycycline + the guided second agent). Blind re-dosing often fails; the resistance-guided treatment works.
Does it cause PID?
Yes — it contributes to cervicitis and PID alongside chlamydia/gonorrhea. The female cases are managed as seriously as the other causes of PID.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
Related Health Guides
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: October 19, 2026 |Clinic: Thamel Clinic |Licensed: Registered